SOPH

SOPHiA GENETICS (SOPH)

About SOPHiA GENETICS (SOPH)

SOPHiA GENETICS SA is a healthcare technology company, which engages in the practice of data driven medicine as the standard of care and for life sciences research. It operates through the following geographical segments: France, Italy, United States, Spain, Turkey, Austria, Brazil, United Kingdom, Switzerland, Germany, and Other. It is the creator of the SOPHiA DDM Platform, a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The company was founded by Jurgi Camblong, Pierre Hutter and Lars Steinmetz in 2011 and is headquartered in Saint Sulpice, Switzerland.

Details

Daily high
$4.89
Daily low
$4.69
Price at open
$4.69
52 Week High
$5.30
52 Week Low
$2.58
Market cap
320.2M
Dividend yield
0.00%
Volume
54,453
Avg. volume
107,014
P/E ratio
-4.23

SOPHiA GENETICS News

Details

Daily high
$4.89
Daily low
$4.69
Price at open
$4.69
52 Week High
$5.30
52 Week Low
$2.58
Market cap
320.2M
Dividend yield
0.00%
Volume
54,453
Avg. volume
107,014
P/E ratio
-4.23